Secondary Bacterial Infections Associated with Influenza Pandemics

Lower and upper respiratory infections are the fourth highest cause of global mortality (Lozano et al., 2012). Epidemic and pandemic outbreaks of respiratory infection are a major medical concern, often causing considerable disease and a high death toll, typically over a relatively short period of t...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in microbiology Vol. 8; p. 1041
Main Authors: Morris, Denise E, Cleary, David W, Clarke, Stuart C
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 23-06-2017
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Lower and upper respiratory infections are the fourth highest cause of global mortality (Lozano et al., 2012). Epidemic and pandemic outbreaks of respiratory infection are a major medical concern, often causing considerable disease and a high death toll, typically over a relatively short period of time. Influenza is a major cause of epidemic and pandemic infection. Bacterial co/secondary infection further increases morbidity and mortality of influenza infection, with , , and reported as the most common causes. With increased antibiotic resistance and vaccine evasion it is important to monitor the epidemiology of pathogens in circulation to inform clinical treatment and development, particularly in the setting of an influenza epidemic/pandemic.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Reviewed by: Jeanette Teo, National University Hospital, Singapore; Siomar De Castro Soares, Universidade Federal do Triângulo Mineiro, Brazil; Chanwit Tribuddharat, Siriraj Hospital, Thailand
This article was submitted to Evolutionary and Genomic Microbiology, a section of the journal Frontiers in Microbiology
Edited by: Chew Chieng Yeo, Universiti Sultan Zainal Abidin, Malaysia
ISSN:1664-302X
1664-302X
DOI:10.3389/fmicb.2017.01041